Bannix Acquisition Corp. Announces Monthly Extension to Complete its Initial Business Combination
March 18, 2024 08:00 ET | Bannix Acquisition Corp.
WEST HOLLYWOOD, Calif., March 18, 2024 (GLOBE NEWSWIRE) -- Bannix Acquisition Corp. (“Bannix”) announced today that its board of directors (the “Board”) has decided to extend the date by which...
eyepoint logo.png
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
March 18, 2024 07:00 ET | EyePoint Pharmaceuticals, Inc.
WATERTOWN, Mass., March 18, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of...
Logo-issuance.swiss-AG-small-2.png
The Swiss Stock Exchange Welcomes CASL, A Disruptive Staking Crypto Product: Cardano Staking ETP by Liqwid (CASL)
March 18, 2024 02:00 ET | issuance.swiss AG
Zurich, March 18th, 2024 - The Switzerland-based protocol Liqwid Finance, in partnership with the issuer Issuance.Swiss AG, is launching CASL, an innovative ETP in the world of staking digital assets....
Logo-issuance.swiss-AG-small-2.png
La bourse suisse accueille CASL, un produit crypto disruptif : l’ETP Cardano Staking ETP by Liqwid (CASL)
March 18, 2024 02:00 ET | issuance.swiss AG
Zurich, 18 mars 2024– La jeune pousse suisse Liqwid Finance lance, en partenariat avec l’émetteur Issuance.Swiss AG, CASL, un ETP résolument nouveau dans l’univers des actifs numériques. Il permet non...
Psyence Biomed logo.png
Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares
March 15, 2024 16:30 ET | Psyence Biomedical Ltd.
NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (the “Company”) (Nasdaq: PBM) announced that on March 11, 2024, it received two letters from the listing qualifications...
2020-0227 Cognition Logo for GNW.png
Cognition Therapeutics Announces Closing of $11.5 Million Public Offering of Common Stock
March 14, 2024 16:05 ET | Cognition Therapeutics, Inc.
PURCHASE, N.Y., March 14, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (“Cognition,” the “Company” or “We”) (Nasdaq: CGTX), a clinical stage company developing product candidates designed...
Graphjet Logo 1147x445px-01.png
Graphjet Technology, The World’s Only Direct Biomass-to-Graphite Producer, Completes Transaction and Will Begin Trading on Nasdaq
March 14, 2024 12:37 ET | Graphjet Technology Sdn Bhd; Energem Corp.
Graphjet, utilizing its proven, commercial and patented technologies to sustainably produce graphite from agricultural waste, becomes the leading source of graphite and graphene for the U.S. market ...
Invited.png
Invited Announces Commencement of Partial Tender Offer for its 8.50% Senior Notes due 2025
March 13, 2024 16:05 ET | Invited
DALLAS, March 13, 2024 (GLOBE NEWSWIRE) -- Invited, Inc. announced today that ClubCorp Holdings, Inc., its indirect wholly-owned subsidiary (the “Company”), has commenced a partial tender offer to...
Factors that impact investors' judgment
Entire industries vs specific stocks: What are the factors that impact investors’ judgment?
March 13, 2024 07:35 ET | MIT Sloan School of Management
Cambridge, MA, March 13, 2024 (GLOBE NEWSWIRE) -- Entire industries vs specific stocks: What are the factors that impact investors’ judgment?  New MIT Sloan research shows how rational inattention...
Logo.jpg
ODDITY Announces Secondary Offering of Class A Ordinary Shares
March 12, 2024 16:16 ET | Oddity Tech Ltd.
NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- ODDITY Tech Ltd. (“ODDITY”) today announced the commencement of an underwritten secondary public offering of 4,000,000 of ODDITY’s Class A ordinary...